ASX
167 days, 6 hours ago 
FCG
Freedom Care Group Holdings Limited
Continuation of Suspension from Quotation
Freedom Care Group Holdings Limited's securities will remain suspended from quotation due to inadequate financial condition following the appointment of voluntary administrators to its subsidiary.
Worse than expected
 

ASX
184 days, 6 hours ago 
FCG
Freedom Care Group Holdings Limited
Results of Meeting
Freedom Care Group Holdings Limited's Annual General Meeting saw all resolutions passed by shareholders, including the re-election of a director and approval of an option share trust plan and additional placement facility.
Capital raise
 

ASX
191 days, 1 hours ago 
FCG
Freedom Care Group Holdings Limited
Response to ASX Query Letter
Australian-listed Freedom Care Group Holdings (ASX: FCG) faced an ASX query regarding delayed disclosure of an NDIA payment suspension and potential NDIS registration revocation, leading to a significant share price drop.
Delay expected
 
Worse than expected
 

ASX
201 days, 10 hours ago 
FCG
Freedom Care Group Holdings Limited
Trading Halt
Freedom Care Group Holdings Limited (FCG) has requested a trading halt pending an announcement regarding discussions with the National Disability Insurance Agency (NDIS) about a payment suspension.
Worse than expected
 

ASX
207 days, 9 hours ago 
FCG
Freedom Care Group Holdings Limited
Market update regarding NDIS Notices
Freedom Care Group Holdings Limited (ASX: FCG) faces potential NDIS registration revocation and a banning order after receiving preliminary notices from the NDIS Quality and Safeguards Commission, impacting approximately 80% of the company's revenue.
Worse than expected
 
Delay expected
 

ASX
215 days, 1 hours ago 
FCG
Freedom Care Group Holdings Limited
Notice of Annual General Meeting/Proxy Form
Freedom Care Group Holdings Limited (FCG) has announced its 2024 Annual General Meeting (AGM) will be held on November 29, 2024, in Sydney, Australia, with shareholders urged to review the Notice of Meeting and Explanatory Memorandum.
Capital raise
 

ASX
215 days, 3 hours ago 
FCG
Freedom Care Group Holdings Limited
FCG Announces New CFO Appointment
Freedom Care Group Holdings Ltd (ASX: FCG) has appointed Tony Mitchell as its new Chief Financial Officer, bringing over 30 years of experience in corporate finance and restructuring to the leading Australian NDIS service provider.

ASX
305 days, 2 hours ago 
FCG
Freedom Care Group Holdings Limited
Quarterly Activities/Appendix 4C Cash Flow Report
Freedom Care Group Holdings Limited reports positive operating cash flow for the June 2024 quarter and highlights ongoing growth initiatives.

ASX
396 days, 9 hours ago 
FCG
Freedom Care Group Holdings Limited
Investor Presentation
Freedom Care Group Holdings Ltd (ASX:FCG), a dedicated NDIS disability support services provider, presents its investor presentation in April 2024, highlighting its business model, growth strategies, and financial performance.
Delay expected
 

ASX
404 days, 3 hours ago 
FCG
Freedom Care Group Holdings Limited
Quarterly Activities/Appendix 4C Cash Flow Report
Freedom Care Group Holdings Limited reports positive cash flow and revenue growth in its Plan Management and Accommodation businesses for the quarter ended March 31, 2024.

FCG 
Freedom Care Group Holdings Limited 
ASX

Investor Presentation

Sentiment:
 Investor Presentation
 30 April 2024 7:22 PM

Freedom Care Group Holdings Ltd (ASX:FCG), a dedicated NDIS disability support services provider, presents its investor presentation in April 2024, highlighting its business model, growth strategies, and financial performance.

Delay expected
  Timing of receipts from debtors impacted revenues for the Mar-24 quarter, with these revenues expected to be booked in the Jun-24 quarter. 

Summary
  • Freedom Care Group (FCG) is an NDIS disability support services provider specializing in complex cases and accommodation needs.
  • The company generates high-quality revenue, with 95% coming from the Australian Government.
  • FCG operates with a low capital-intensive business model and boasts a high return on equity.
  • Recurring revenue accounts for 70% to 80% of FCG's income.
  • The company is profitable, cash flow positive, and debt-free.
  • FCG's organic growth strategy focuses on replicating its successful model and increasing service capacity to over 15,000 hours per week within three years.
  • FCG aims to expand through acquisitions, targeting companies with a turnover of $3 million or greater.
  • As of April 26, 2024, FCG's share price was 18.0 cents, with a market capitalization of $19.5 million.
  • The company held $4.2 million in cash as of March 31, 2024.
  • The projected number of NDIS participants is expected to increase to 1,152,552 by 2035, from 646,449 as of December 31, 2023.
Sentiment

Score: 7

Explanation: The presentation is generally positive, highlighting strong revenue, profitability, and growth opportunities. However, the disclaimer and mention of one-off expenses temper the overall sentiment.

Positives
  • High-quality revenue stream with 95% government funding.
  • Low capital-intensive business model leading to high return on equity.
  • Recurring revenue provides stability (70-80%).
  • Profitable with positive cash flow and no debt.
  • Experienced management team.
  • Solid opportunities for organic growth and expansion.
  • Unique ASX listing as the first NDIS support services provider.
  • Meets ESG investment criteria.
Negatives
  • One-off IPO-related expenses of around $1.7 million impacted profitability in H1 FY24.
  • Timing of receipts from debtors impacted revenues for the Mar-24 quarter.
Risks
  • Forward-looking statements are subject to risks and uncertainties, and actual outcomes may differ.
  • The company's growth strategy depends on replicating its successful model and successfully integrating acquisitions.
  • The distribution of the presentation in jurisdictions outside of Australia may be restricted by law.
Future Outlook

The company expects strong participant growth and plans to increase its service capacity to over 15,000 hours per week within three years organically. FCG also intends to expand through acquisitions.

Management Comments
  • Freedom Care prioritizes the growth of its current operations.
  • FCG organic expansion strategy focuses on replicating its successful model, substantial increase in revenue.
Industry Context

The presentation highlights FCG as the first NDIS support services provider listed on the ASX, indicating a growing interest in the disability support sector within the investment community. The increasing number of NDIS participants also suggests a favorable market environment for providers.

Comparison to Industry Standards
  • The document does not provide specific comparisons to industry standards or competitors.
  • Without detailed financial benchmarks or competitor analysis, it's difficult to assess FCG's performance relative to industry peers.
  • Companies like APM and MedHealth are significant players in the broader healthcare and disability services market, but direct comparisons would require more specific data.
Stakeholder Impact
  • Shareholders: Potential for increased value through organic growth and acquisitions.
  • Employees: Opportunities for career advancement as the company expands.
  • Customers (NDIS Participants): Improved access to quality care and support services.
  • Suppliers: Increased business opportunities as FCG's operations grow.
  • Creditors: Low risk due to the company's debt-free status.
Next Steps
  • Focus on organic growth and replicating the successful business model.
  • Pursue strategic acquisitions to expand geographically and enhance service offerings.
  • Increase service capacity to over 15,000 hours per week within three years.
  • Book revenues delayed from the Mar-24 quarter in the Jun-24 quarter.
Key Dates
  • December 31, 2023: NDIS participants at 646,449
  • March 31, 2024: Cash balance of $4.2 million
  • April 26, 2024: Share price at 18.0 cents
  • 2035: Projected number of NDIS participants at 1,152,552
Keywords

FCG 
Freedom Care Group Holdings Limited 
ASX
Sector: Health Care Equipment & Services
 
Filings with Classifications
Worse than expected
15 December 2024 8:49 PM

Suspension Update
  • The company's securities remain suspended due to inadequate financial condition and breach of listing rules, which is a worse outcome than expected.
Capital raise
28 November 2024 9:20 PM

Annual General Meeting Results
  • The approval of an additional 10% placement facility suggests a potential future capital raise.
Worse than expected
22 November 2024 2:42 AM

Response to ASX Query
  • The significant drop in share price following the delayed disclosure of the NDIA payment suspension and potential NDIS registration revocation indicates worse-than-expected results for investors.
  • The negative operating cash flow and the potential loss of a significant portion of revenue due to the NDIS issues point to worse-than-expected financial performance.
Delay expected
22 November 2024 2:42 AM

Response to ASX Query
  • The company delayed disclosing the NDIA payment suspension and the notices from the NDIS Quality and Safeguards Commission, which were considered material information that should have been disclosed earlier.
Worse than expected
11 November 2024 5:12 PM

Trading Halt Announcement
  • The trading halt announcement indicates a negative development, as it suggests a disruption in payments from the NDIS, impacting FCG's financial stability.
Worse than expected
5 November 2024 6:03 PM

Market Update
  • The preliminary notices from the NDIS Quality and Safeguards Commission regarding potential registration revocation and a banning order represent significantly worse-than-expected news for Freedom Care Group.
Delay expected
5 November 2024 6:03 PM

Market Update
  • The protracted review of FCGPL's support services claims has resulted in a payment suspension from the NDIS.
Capital raise
29 October 2024 2:57 AM

Annual General Meeting Notice
  • The company is seeking shareholder approval for an additional 10% placement facility, allowing them to issue equity securities up to 10% of their issued capital.
  • The funds raised will be used for continued exploration expenditure and/or general working capital.
Delay expected
30 April 2024 7:22 PM

Investor Presentation
  • Timing of receipts from debtors impacted revenues for the Mar-24 quarter, with these revenues expected to be booked in the Jun-24 quarter.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.